Regenerative Medical Technology Group Inc. (RMTG) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Regenerative Medical Technology Group Inc. (RMTG) stock forecast summary
Our AI ranks Regenerative Medical Technology Group Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Regenerative Medical Technology Group Inc. is a small-cap company with a market capitalization of $660K. It ranks number 13 by market capitalization among the 15 Retail-Retail Stores, NEC issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for RMTG is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, RMTG included.
Follow RMTG freeRMTG price chart and AI forecast
How RMTG ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Regenerative Medical Technology Group Inc. (RMTG) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Retail Stores, NEC peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | RMTG | Rank |
|---|---|---|
| Market Cap | $660K | 13/15 |
| EPS | $-0.51 | – |
Profitability & Margins
| Metric | RMTG | Rank |
|---|---|---|
| ROIC | -0.3% | 6/12 |
| Gross Margin | 60.2% | 3/11 |
| Operating Margin | 1.1% | 5/11 |
| EBT Margin | -0.2% | 6/11 |
Financial Health
| Metric | RMTG | Rank |
|---|---|---|
| Current Ratio | 0.05x | 12/13 |
| Quick Ratio | 0.04x | 11/11 |
| Working Capital | -$40M | 11/12 |
Cash Flow
| Metric | RMTG | Rank |
|---|---|---|
| Operating Cash Flow | -$370K | 10/12 |
Operational Efficiency
| Metric | RMTG | Rank |
|---|---|---|
| Inventory Turnover | 5.2x | 3/10 |
| Days Inventory | 70 days | 8/10 |
| Payables Period | 12 days | 9/10 |
Income Statement
| Metric | RMTG | Rank |
|---|---|---|
| Operating Income | $0.00M | 6/12 |
| Cost of Goods Sold | $3M | 11/11 |
Dividend & Shareholder Information
| Metric | RMTG | Rank |
|---|---|---|
| Shares Outstanding | 14M | – |
| EPS Growth | -1067.0% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $2M | 39.0% of assets |
| Cash & Short-term Investments | $1M | 22.6% of assets |
| Accounts Receivable | $110K | 1.9% of assets |
| Inventory | $480K | 8.2% of assets |
| Total Liabilities | $45M | 772.4% of assets |
| Short-term Debt | $43M |
RMTG quarterly financials and insider trading
Regenerative Medical Technology Group Inc. (RMTG) industry peers
Companies classified under the same SEC industry code as Regenerative Medical Technology Group Inc. (Retail-Retail Stores, NEC): 18 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| RMTG Regenerative Medical Technology Group Inc. | ▲ | $660K |
| JD Jd.Com, Inc. | ▼ | $76.25B |
| ULTA Ulta Beauty, Inc. | ▶ | $24.76B |
| BBWI Bath & Body Works, Inc. | ▶ | $3.63B |
| SBH Sally Beauty Holdings, Inc. | ▼ | $1.49B |
| WOOF Petco Health & Wellness Company, Inc. | ▶ | $781M |
| TITN Titan Machinery Inc. | ▲ | $554M |
| HITI High Tide Inc. | ▶ | $225M |
| FLWS 1 800 Flowers Com Inc | ▲ | $166M |
| BARK Bark, Inc. | ▶ | $72M |
| TKLF Tokyo Lifestyle Co., Ltd. | ▶ | $67M |
| RENT Rent The Runway, Inc. | ▲ | $60M |
| RCT Redcloud Holdings Plc | ▼ | $7M |
| LESL Leslie's, Inc. | ▶ | $560K |
| NSTM Novelstem International Corp. | ▼ | $490K |
| INHD Inno Holdings Inc. | ▶ | N/A |
| NAAS Naas Technology Inc. | ▼ | N/A |
| NEGG Newegg Commerce, Inc. | ▲ | N/A |
Where RMTG sits on the market map
Regenerative Medical Technology Group Inc. (RMTG) stock news
Loading...
Regenerative Medical Technology Group Inc. (RMTG) stock forecast FAQ
What is the Regenerative Medical Technology Group Inc. (RMTG) stock forecast?
Our AI ranks Regenerative Medical Technology Group Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Regenerative Medical Technology Group Inc. stock predictions?
A per-ticker accuracy statistic for RMTG is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Regenerative Medical Technology Group Inc. forecasts updated?
Regenerative Medical Technology Group Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Regenerative Medical Technology Group Inc.'s industry peers?
18 issuers in our coverage, RMTG included, share the SEC industry code Retail-Retail Stores, NEC. The largest are: Jd.Com, Inc. (JD), Ulta Beauty, Inc. (ULTA), Bath & Body Works, Inc. (BBWI), Sally Beauty Holdings, Inc. (SBH), Petco Health & Wellness Company, Inc. (WOOF), Titan Machinery Inc. (TITN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.